{"product_id":"tirzepatide-10mg","title":"Tirzepatide 10mg","description":"\u003cnav aria-label=\"Breadcrumb\" style=\"font-size: 13px; color: #666666; margin: 0 0 16px;\"\u003e\u003ca href=\"\/\" style=\"color: #666666; text-decoration: none;\"\u003eHome\u003c\/a\u003e \/ \u003ca href=\"\/collections\/all\" style=\"color: #666666; text-decoration: none;\"\u003eShop\u003c\/a\u003e \/ \u003cspan style=\"color: #121212;\"\u003eTirzepatide 10mg\u003c\/span\u003e\u003c\/nav\u003e\n\u003ch2\u003eTirzepatide Peptide Research Australia\u003c\/h2\u003e\n\u003cp\u003eTirzepatide (CAS 2023788-19-2, molecular formula C225H348N48O68) is a synthetic dual GIP and GLP-1 receptor agonist peptide studied for its interaction with incretin receptor signalling pathways. PhaseOne supplies Tirzepatide to researchers across Australia as a high-purity lyophilised powder, independently HPLC verified at ≥99% purity per batch.\u003c\/p\u003e\n\u003cp\u003eAs a dual-incretin research peptide, Tirzepatide is studied alongside related metabolic peptides such as \u003ca href=\"\/products\/reta-5mg-10mg-15mg-20mg-30mg\"\u003eRetatrutide\u003c\/a\u003e within Australian peptide research, manufactured to research-grade standards and independently third-party tested for identity and consistency, with every order shipped Australia-wide. (!) Full Certificate of Analysis available for every batch \u003ca href=\"\/blogs\/news\"\u003eview here\u003c\/a\u003e.\u003c\/p\u003e\n\u003cstyle\u003e.pdp-faq-item{border-radius:30px;background-color:#f3f3f3;overflow:hidden;margin-bottom:16px;}.pdp-faq-q{display:flex;align-items:center;justify-content:space-between;padding:20px;cursor:pointer;gap:20px;border:none;background:transparent;width:100%;text-align:left;}.pdp-faq-q h3{font-size:16px;font-weight:600;color:#121212;margin:0;}.pdp-faq-toggle{width:32px;height:32px;flex-shrink:0;display:flex;align-items:center;justify-content:center;background-color:#86b9ec;border-radius:50%;transition:transform 0.3s ease;}.pdp-faq-item.active .pdp-faq-toggle{transform:rotate(45deg);}.pdp-faq-a{max-height:0;overflow:hidden;transition:max-height 0.3s ease,padding 0.3s ease;padding:0 20px;}.pdp-faq-item.active .pdp-faq-a{max-height:500px;padding:0 20px 20px;}.pdp-faq-a p{font-size:14px;color:#121212;line-height:1.6;margin:0;}.pdp-faq-a a{color:#185FA5;}\u003c\/style\u003e\n\u003cdiv class=\"pdp-faq-item\" data-pdp-faq=\"\"\u003e\n\u003ch3\u003eWhat is Tirzepatide?\u003c\/h3\u003e\n\u003cdiv class=\"pdp-faq-toggle\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke-width=\"2\" stroke-linecap=\"round\"\u003e\u003cline x1=\"12\" y1=\"5\" x2=\"12\" y2=\"19\"\u003e\u003c\/line\u003e\u003cline x1=\"5\" y1=\"12\" x2=\"19\" y2=\"12\"\u003e\u003c\/line\u003e\u003c\/svg\u003e\u003c\/div\u003e\n\u003cdiv class=\"pdp-faq-a\"\u003e\n\u003cp\u003eTirzepatide is a synthetic 39-amino-acid peptide and dual GIP\/GLP-1 receptor agonist, studied within Australian peptide research for its interaction with incretin receptor signalling pathways.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pdp-faq-item\" data-pdp-faq=\"\"\u003e\n\u003ch3\u003eHow does Tirzepatide differ from Retatrutide?\u003c\/h3\u003e\n\u003cdiv class=\"pdp-faq-toggle\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke-width=\"2\" stroke-linecap=\"round\"\u003e\u003cline x1=\"12\" y1=\"5\" x2=\"12\" y2=\"19\"\u003e\u003c\/line\u003e\u003cline x1=\"5\" y1=\"12\" x2=\"19\" y2=\"12\"\u003e\u003c\/line\u003e\u003c\/svg\u003e\u003c\/div\u003e\n\u003cdiv class=\"pdp-faq-a\"\u003e\n\u003cp\u003eTirzepatide is a dual GIP\/GLP-1 receptor agonist, whereas Retatrutide is a triple GIP\/GLP-1\/glucagon receptor agonist; the two have distinct receptor profiles studied within metabolic peptide research. (!) Compare them in our \u003ca href=\"\/pages\/peptide-information-guide\/retatrutide-vs-tirzepatide-australia\"\u003eRetatrutide vs Tirzepatide guide\u003c\/a\u003e, or view our \u003ca href=\"\/products\/reta-5mg-10mg-15mg-20mg-30mg\"\u003eRetatrutide\u003c\/a\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pdp-faq-item\" data-pdp-faq=\"\"\u003e\n\u003ch3\u003eStorage \u0026amp; reconstitution\u003c\/h3\u003e\n\u003cdiv class=\"pdp-faq-toggle\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke-width=\"2\" stroke-linecap=\"round\"\u003e\u003cline x1=\"12\" y1=\"5\" x2=\"12\" y2=\"19\"\u003e\u003c\/line\u003e\u003cline x1=\"5\" y1=\"12\" x2=\"19\" y2=\"12\"\u003e\u003c\/line\u003e\u003c\/svg\u003e\u003c\/div\u003e\n\u003cdiv class=\"pdp-faq-a\"\u003e\n\u003cp\u003eUnreconstituted Tirzepatide should be stored refrigerated and protected from light, and is commonly reconstituted with bacteriostatic water prior to research preparation. (!) Read our \u003ca href=\"\/pages\/peptide-information-guide\/peptide-reconstitution-guide-australia\"\u003ereconstitution guide\u003c\/a\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pdp-faq-item\" data-pdp-faq=\"\"\u003e\n\u003ch3\u003eHow is purity verified?\u003c\/h3\u003e\n\u003cdiv class=\"pdp-faq-toggle\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke-width=\"2\" stroke-linecap=\"round\"\u003e\u003cline x1=\"12\" y1=\"5\" x2=\"12\" y2=\"19\"\u003e\u003c\/line\u003e\u003cline x1=\"5\" y1=\"12\" x2=\"19\" y2=\"12\"\u003e\u003c\/line\u003e\u003c\/svg\u003e\u003c\/div\u003e\n\u003cdiv class=\"pdp-faq-a\"\u003e\n\u003cp\u003eEach PhaseOne batch is independently verified by third-party HPLC analysis, with a Certificate of Analysis available for every order shipped across Australia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pdp-faq-item\" data-pdp-faq=\"\"\u003e\n\u003ch3\u003eWhat research category does Tirzepatide fall under?\u003c\/h3\u003e\n\u003cdiv class=\"pdp-faq-toggle\"\u003e\u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke-width=\"2\" stroke-linecap=\"round\"\u003e\u003cline x1=\"12\" y1=\"5\" x2=\"12\" y2=\"19\"\u003e\u003c\/line\u003e\u003cline x1=\"5\" y1=\"12\" x2=\"19\" y2=\"12\"\u003e\u003c\/line\u003e\u003c\/svg\u003e\u003c\/div\u003e\n\u003cdiv class=\"pdp-faq-a\"\u003e\n\u003cp\u003eTirzepatide is studied within the metabolic and incretin (GLP-1 class) peptide research category. (!) Explore our \u003ca href=\"\/pages\/peptide-information-guide\/glp1-peptide-guide-australia\"\u003eGLP-1 peptide guide\u003c\/a\u003e and \u003ca href=\"\/pages\/peptide-information-guide\/metabolic-peptide-guide-australia\"\u003emetabolic peptide guide\u003c\/a\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003chr\u003e\n\u003ch2\u003eDisclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products supplied by PhaseOne are intended strictly for laboratory research purposes only. Products are not intended for human consumption, therapeutic use, cosmetic use, veterinary use, or diagnostic applications.\u003c\/p\u003e","brand":"PhaseOne","offers":[{"title":"Default Title","offer_id":40837298782337,"sku":null,"price":109.99,"currency_code":"AUD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0609\/4739\/8785\/files\/tirz10.png?v=1785159852","url":"https:\/\/phaseoneaus.com\/products\/tirzepatide-10mg","provider":"PhaseOne","version":"1.0","type":"link"}